References
- Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ: Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 45;1-36, 2003. https://doi.org/10.1016/S1040-8428(02)00078-1
- Thorley-Lawson DA, Babcock GJ: A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. Life Sci 65;1433-1453, 1999. https://doi.org/10.1016/S0024-3205(99)00214-3
- Dolcetti R, Masucci MG: Epstein-Barr virus: induction and control of cell transformation. J Cell Physiol 196;207-218, 2003. https://doi.org/10.1002/jcp.10263
- Comito MA, Sun Q, Lucas KG: Immunotherapy for Ep stein- Barr virus-associated tumors. Leuk Lymphoma 45;1981-1987, 2004. https://doi.org/10.1080/10428190410001700831
- Neitzel H: A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 73;320- 326, 1986. https://doi.org/10.1007/BF00279094
- Hur DY, Lee MH, Kim JW, Kim JH, Shin YK, Rho JK, Kwack KB, Lee WJ, Han BG: CD19 signalling improves the Epstein- Barr virus-induced immortalization of human B cell. Cell Prolif 38;35-45, 2005. https://doi.org/10.1111/j.1365-2184.2005.00328.x
- Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C: B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366;76-79, 1993. https://doi.org/10.1038/366076a0
- Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, Nadler LM: Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262;909-911, 1993. https://doi.org/10.1126/science.7694363
- Larsen CP, Ritchie SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Lowry RP, Pearson TC: Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 152; 5208-5219, 1994.
- Zheng P, Wu Y, Guo Y, Lee C, Liu Y: B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge. Proc Natl Acad Sci USA 95;6284-6289, 1998. https://doi.org/10.1073/pnas.95.11.6284
- Gordon J, Millsum MJ, Guy GR, Ledbetter JA: Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling. J Immunol 140;1425-1430, 1988.
- Goldstein MD, Watts TH: Identification of distinct domains in CD40 involved in B7-1 induction or growth inhibition. J Immunol 157;2837-2843, 1996.
- Nakajima A, Kodama T, Morimoto S, Azuma M, Takeda K, Oshima H, Yoshino S, Yagita H, Okumura K: Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7. J Immunol 161;1901-1907, 1998.
- Bergamo A, Bataille R, Pellat-Deceunynck C: CD40 and CD95 induce programmed cell death in the human myeloma cell line XG2. Br J Haematol 97;652-655, 1997. https://doi.org/10.1046/j.1365-2141.1997.1032919.x
- Mongini PK, Tolani S, Fattah RJ, Inman JK: Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: augmenting role of the CD21/CD19 co-stimulatory complex and IL-4. Cell Immunol 216;50-64, 2002. https://doi.org/10.1016/S0008-8749(02)00512-9
- Evans DE, Munks MW, Purkerson JM, Parker DC: Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40. J Immunol 164;688-697, 2000. https://doi.org/10.4049/jimmunol.164.2.688
- Clatza A, Bonifaz LC, Vignali DA, Moreno J: CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation. J Immunol 171;6478-6487, 2003. https://doi.org/10.4049/jimmunol.171.12.6478
- Bluestone JA: New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2;555-559, 1995. https://doi.org/10.1016/1074-7613(95)90000-4
- Jirapongsananuruk O, Hofer MF, Trumble AE, Norris DA, Leung DY: Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis. J Immunol 160;4622-4627, 1998.
- Ikemizu S, Gilbert RJ, Fennelly JA, Collins AV, Harlos K, Jones EY, Stuart DI, Davis SJ: Structure and dimerization of a soluble form of B7-1. Immunity 12;51-60, 2000. https://doi.org/10.1016/S1074-7613(00)80158-2
- Bajorath J, Peach RJ, Linsley PS: Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86). Protein Sci 3; 2148-2150, 1994. https://doi.org/10.1002/pro.5560031128
- Heath AW, Chang R, Harada N, Santos-Argumedo L, Gordon J, Hannum C, Campbell D, Shanafelt AB, Clark EA, Torres R, Howard M: Antibodies to murine CD40 stimulate normal B cells but inhibit proliferation of B lymphoma cells. Cell Immunol 152;468-480, 1993. https://doi.org/10.1006/cimm.1993.1305
- Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, Jacoby D, Strom TB, Simpson EM, Freeman GJ, Sharpe AH: B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6;303-313, 1997. https://doi.org/10.1016/S1074-7613(00)80333-7
- Suvas S, Singh V, Sahdev S, Vohra H, Agrewala JN: Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J Biol Chem 277;7766-7775, 2002. https://doi.org/10.1074/jbc.M105902200
- Lukas Z, Dvorak K: Review article adhesion molecules in biology and oncology. Acta Vet Brno 73;93-104, 2004.
- Roebuck KA, Finnegan A: Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 66;876- 888, 1999. https://doi.org/10.1002/jlb.66.6.876
- Rincon J, Prieto J, Patarroyo M: Expression of integrins and other adhesion molecules in Epstein-Barr virus-transformed B lymphoblastoid cells and Burkitt's lymphoma cells. Int J Cancer 51;452-458, 1992. https://doi.org/10.1002/ijc.2910510319
- Mehl AM, Floettmann JE, Jones M, Brennan P, Rowe M: Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein- 1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription. J Biol Chem 276;984-992, 2001. https://doi.org/10.1074/jbc.M003758200
- Kosco MH, Pflugfelder E, Gray D: Follicular dendritic cell-dependent adhesion and proliferation of B cells in vitro. J Immunol 148;2331-2339, 1992.
- Koopman G, Keehnen RM, Lindhout E, Newman W, Shimizu Y, van Seventer GA, de Groot C, Pals ST: Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol 152;3760-3767, 1994.
- Gonzalo JA, Martinez C, Springer TA, Gutierrez-Ramos JC: ICAM-1 is required for T cell proliferation but not for anergy or apoptosis induced by Staphylococcus aureus enterotoxin B in vivo. Int Immunol 7;1691-1698, 1995. https://doi.org/10.1093/intimm/7.10.1691